Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Guillain-Barré syndrome: clinical profile and management.
The potential role of epigenetic modifications in the heritability of multiple sclerosis.
Clinical and MRI characterization of MS patients with a pure and severe cognitive onset.
Rare variants in the CYP27B1 gene are associated with multiple sclerosis.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study.
The history of the oxazaphosphorine cytostatics.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Daclizumab (anti-CD25) in multiple sclerosis.
MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1R ) and receptor-5 (S1P5R ) agonist with autoimmune disease-modifying activity.
English Court of Appeal finds in favor of Teva on Copaxone(R) patent litigation and upholds validity of Copaxone patent until May 2015
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis.
Lipocalin 2 is present in the EAE brain and is modulated by natalizumab.
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.
Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs.
Pregnancy outcomes in female patients and partners of male patients in the teriflunomide clinical development program.
Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects.
Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response.
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.
SIRT1 deacetylates RORγt and enhances Th17 cell generation.

Pages